1. Home
  2. ELUT vs NNVC Comparison

ELUT vs NNVC Comparison

Compare ELUT & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.93

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.11

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
NNVC
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.5M
35.2M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
ELUT
NNVC
Price
$0.93
$1.11
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
54.4K
279.0K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
146.77
10.00
EPS
N/A
N/A
Revenue
$12,293,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.85
52 Week High
$1.51
$2.23

Technical Indicators

Market Signals
Indicator
ELUT
NNVC
Relative Strength Index (RSI) 47.42 25.99
Support Level $0.84 $1.10
Resistance Level $1.04 $1.29
Average True Range (ATR) 0.08 0.06
MACD -0.01 -0.01
Stochastic Oscillator 29.88 8.62

Price Performance

Historical Comparison
ELUT
NNVC

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: